Cargando…
ROS as a novel indicator to predict anticancer drug efficacy
BACKGROUND: Mitochondria are considered a primary intracellular site of reactive oxygen species (ROS) generation. Generally, cancer cells with mitochondrial genetic abnormalities (copy number change and mutations) have escalated ROS levels compared to normal cells. Since high levels of ROS can trigg...
Autores principales: | Zaidieh, Tarek, Smith, James R., Ball, Karen E., An, Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916036/ https://www.ncbi.nlm.nih.gov/pubmed/31842863 http://dx.doi.org/10.1186/s12885-019-6438-y |
Ejemplares similares
-
Mitochondrial DNA abnormalities provide mechanistic insight and predict reactive oxygen species-stimulating drug efficacy
por: Zaidieh, Tarek, et al.
Publicado: (2021) -
Correction to: Mitochondrial DNA abnormalities provide mechanistic insight and predict reactive oxygen species-stimulating drug efficacy
por: Zaidieh, Tarek, et al.
Publicado: (2021) -
Superparamagnetic Iron Oxide Nanoparticles: Amplifying ROS Stress to Improve Anticancer Drug Efficacy
por: Huang, Gang, et al.
Publicado: (2013) -
Identification of Chaetocin as a Potent non-ROS-mediated Anticancer Drug Candidate for Gastric Cancer
por: Liao, Xinwen, et al.
Publicado: (2019) -
Understanding of ROS-Inducing Strategy in Anticancer Therapy
por: Kim, Su Ji, et al.
Publicado: (2019)